Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
advances in neurology
adverse drug reaction
aggrenox
air transport
Alberta Stroke Program Early CT score
algorithm
andexanet
aneurysm, intracranial
angiography, neurologic complications with
angiotensin-converting enzyme, inhibitors
anterior cerebral artery, occlusion of
anticoagulant, complications of
anticoagulant, reversal of
anticoagulant, treatment
anticoagulant, treatment in CVD
antihypertensive
aptiganel
arterial dissection
arterial dissection, basilar
arterial dissection, carotid
arterial dissection, recurrent
arterial dissection, vertebral
arterial perforation
Asians
aspirin
aspirin, dose of
ataxia
atorvastatin
atrial fibrillation
atrial fibrillation, risk stratification
atrial myxoma
atypical
AURORA
baroreceptors
BASICS trial
basilar artery occlusion
basilar artery plaque
basilar artery stenosis
BASIS trial
BEST trial
blacks
blood pressure
blood pressure after stroke
brainstem, infarction of
brainstem, lesion of
call 911
cardioseal device
cardiovascular disease
carotid angiogram
carotid artery disease
carotid artery disease, medical management
carotid artery occlusion, intracranial
carotid artery occlusion, neck
carotid artery stenosis
carotid artery stenosis, intracranial
carotid-siphon stenosis
CASSISS trial
CAT scan
CAT scan, abnormal
CAT scan, angiography
CAT scan, contrast extravasation
CAT scan, dense artery sign
CAT scan, mismatch between cerebral blood volume/flow
CAT scan, mismatch between perfusion/diffusion
CAT scan, perfusion
cerebellar infarction
cerebral atherosclerosis
cerebral atherosclerosis, medical management
cerebral embolism
cerebral embolism, mechanical extraction
cerebral infarction
cerebral infarction, hemorrhagic
cerebral infarction, small, deep
cerebral ischemia
cerebral venous infarction
cerebral venous thrombosis
cerebral venous thrombosis, etiology
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, adolescent
cerebrovascular accident, age of lesion
cerebrovascular accident, anticoagulant treatment
cerebrovascular accident, awakening with
cerebrovascular accident, cardiac disease causing
cerebrovascular accident, classification
cerebrovascular accident, complications with
cerebrovascular accident, cost of
cerebrovascular accident, delay in treatment
cerebrovascular accident, etiology
cerebrovascular accident, infancy and childhood
cerebrovascular accident, large
cerebrovascular accident, large ischemic core
cerebrovascular accident, nonarterial territory
cerebrovascular accident, nontreatment of
cerebrovascular accident, pathophysiology
cerebrovascular accident, platelet inhibiting drugs in treatment
cerebrovascular accident, prehospital screening
cerebrovascular accident, prehospital treatment
cerebrovascular accident, prevention of
cerebrovascular accident, primary prevention
cerebrovascular accident, prognosis in
cerebrovascular accident, racial differences
cerebrovascular accident, recurrent
cerebrovascular accident, rehabilitation of
cerebrovascular accident, secondary prevention
cerebrovascular accident, severity
cerebrovascular accident, sex distribution
cerebrovascular accident, surgical treatment of
cerebrovascular accident, thrombolytic agents in treatment
cerebrovascular accident, thromobolytic agents in treatment, early dramatic recovery
cerebrovascular accident, time of onset
cerebrovascular accident, time of presentation
cerebrovascular accident, time to treatment
cerebrovascular accident, unknown time of onset
cerebrovascular accident, volume
cerebrovascular accident, women
cerebrovascular accident, work up for
cerebrovascular accident, young adult
cerebrovascular disease
cerebrovascular disease, risk factors in
cerebrovascular disease, treatment of
CHADS-VaSC score
CHANCE Trial
CHOICE trial
cholesterol
citicoline
clinical mismatch
Clinical Pathologic Conference(C.P.C.)
clinical trials
clopidogrel
CLOSURE I trial
clot retrieval
collateral circulation
color desaturation
coma
complications
controversies in neurology
coronavirus
cortical infarction, small
cortical vein thrombosis
cost
cost effectiveness
coumarin
COVID-19
craniectomy, decompressive
critical pathway
dabigatran
dabigatran, dose
DAWN stroke trial
decerebrate posture
DEFUSE study
dense basilar artery sign
dense middle cerebral artery sign
diplopia
dipyridamole
disability rating scale, neurological
disability, neurological
diuretic
dizziness
doll's head maneuver
door to imaging time
door to needle time
door to reperfusion time
door to treatment time
drop attacks
dural sinus thrombosis
dysarthria
edema, facial
efficacy
embolic stroke of unknown source
embolism
embolism, paradoxical
embolism, vertebral-basilar artery
emergencies, neurologic
emergency medical technicians
endarterectomy, carotid
endarterectomy, carotid-indications for
endovascular photoacoustic recanalization
endovascular therapy
endovascular therapy, late time window
endovascular therapy, selection criteria
endovascular therapy, time window
epidemic
epidemiology of neurology
EPITHET trial
ESCAPE trial
ethics in neurology
EXTEND trial
factor Xa inhibitor
failed medical management
fibrinolytic agents
fibrinolytic agents, combined IA and IV
fibrinolytic agents, complications
fibrinolytic agents, contraindications
fibrinolytic agents, intra-arterial local infusion
fibrinolytic agents, intra-venous local infusion
fibrinolytic therapy, selection criteria
fibrinolytic therapy, timing of administration
fibroblast growth factor
gastrointestinal bleeding
gaze palsy
gender
GOLIATH trial
HAS-BLED score
head injury
headache
headache, thunderclap
hemorrhagic diathesis
heparin
heparin, low-molecular-weight
hepatic failure
heprain induced thrombocytopenia
HERMES
herpes simplex encephalitis, diagnosis of
hospital length of stay
hypercoagulable state
hyperintense vessel sign
hypertension
iatrogenic neurologic disorders
idarucizumab
indapamide
informed consent
INR value, time in range
INR values
internal carotid artery
intracerebral hemorrhage
intracranial hemorrhage
intracranial pressure, increased
ischemic core
ischemic penumbra
lawsuit
lipid lowering agent
lipids
liver disease
liver function enzymes
locked-in syndrome
malpractice
mastoiditis
MATCH trial
medical-legal aspects of neurology
MERCI trial
middle cerebral artery
middle cerebral artery atherosclerosis
middle cerebral artery territory infarction
middle cerebral artery, branch occlusion
middle cerebral artery, occlusion of
middle cerebral artery, stenosis of
misdiagnosis
mobile interventional stroke teams
mortality
MR CLEAN
MR WITNESS trial
MRI
MRI, abnormal
MRI, CAT scan compared to
MRI, cerebrovascular disease
MRI, diffusion weighted
MRI, early changes in CVA
MRI, FLAIR, hyperintense vessels
MRI, mismatch between DWI/FLAIR
MRI, mismatch between perfusion/diffusion
MRI, perfusion
MRI, volumetry
multimodal neuroimaging
neoplasm, intracranial-incidence and epidemiology of
neurologic consultation
neurologic disease, diagnoses of
neurologic examination, focal
neurologic recovery
neurologic signs
neurologic symptoms
neuroprotective agents
neuroradiology, interventional
NIH stroke scale
NMDA antagonists
non-vitamin K antagonist oral anticoagulants
nystagmus
old age, neurology of
outcome research
palliative care
patent foramen ovale
patent foramen ovale, percutaneous closure
patient information and support
patient selection
Penumbra System
perindopril
platelet inhibiting drugs
platelet inhibiting drugs, combined
POINT trial
pons, infarction of
posterior cerebral artery occlusion
posterior circulation stroke
practice guidelines
prevention of neurologic disorders
PROFESS trial
prognosis
PROGRESS trial
quality of life
ramipril
Rankin score
RAPID CT perfusion maps
recanalization, arterial
recanalization, venous
recurrent
rehabilitation for neurologic disorders
RELY trial
reperfusion
research
RESPECT trial
Retriever Device
REVASCAT trials
revascularization, surgical
review article
risk factors
risk factors, modification
risk-benefit assessment
rivaroxaban
ROCKET - AF trial
safety
screening
seizure
seizure, focal
serum alanine aminotransferase
solitaire device
SPARCL trial
SPORTIF trial
STARFlex septal closure system
statin therapy
stent, carotid artery
stent, coronary artery
stent, intracranial
stent, middle cerebral artery
stent, vertebral artery
streptokinase
stroke center
stroke disability scale
stroke protocol
stroke unit, mobile
subarachnoid hemorrhage
subdural hematoma
superior sagittal sinus thrombosis
SWIFT PRIME Trials
SWIFT trial
symptomatic
T lesion of MCA-ICA
telemedicine
teleneurology
telestroke
tenecteplase
thrombectomy
thrombectomy, distal occlusion
thrombin inhibitor
thromboaspiration
thrombolysis, mechanical
time is brain
TIMELESS trial
tissue plasminogen activator, intravenous
transient ischemic attack
transient ischemic attack, treatment of
transluminal angioplasty, basilar artery
transluminal angioplasty, carotid artery
transluminal angioplasty, intracranial
transluminal angioplasty, intracranial-indications for
transluminal angioplasty, middle cerebral artery
transluminal angioplasty, vertebral artery
transport of patient
trauma
treatment delay
treatment of neurologic disorder
Trevo retriever
trial design
unconsciousness
unconsciousness, transient
urokinase
vaccination, neurologic complications with
vaccine
vertebral artery
vertebral artery occlusion
vertebral artery stenosis
vertebral-basilar artery, atherosclerosis
vertebral-basilar artery, intraluminal clot
vertebral-basilar insufficiency
vertigo
vision, blurred
VISSIT trial
visual field defect
WAKE-UP trial
WASID trial
weakness, generalized
Wingspan study
workup
ximelagatran
Showing articles 1150 to 1200 of 2192 << Previous Next >>

Tissue Plasminogen Activator for Acute Ischemic Stroke in Clinical Practice
Stroke 34:2847-2850, Graham,G.D., 2003

Cholesterol and the Risk of Ischemic Stroke
Stroke 34:2930-2934, Bowman,T.S.,et al, 2003

Teleneurology to Improve Stroke Care in Rural Areas
Stroke 34:2951-2957, Wiborg,A.,et al, 2003

Anticoagulation or Inferior Vena Cava Filter Placement for Patients with Primary Intracerebral Hemorrhage Developing Venous Thromboembolism?
Stroke 34:2999-3005, Kelly,J.,et al, 2003

Stroke Prevention with the Oral Direct Thrombin Inhibitor Ximelagatran Compared with Warfarin in Patients with Non-Valvular Atrial Fibrillation (SPORTIF III): Randomised Controlled Trial
Lancet 362:1691-1698,1686, Executive Steering Committee on Behalf of the SPOR, 2003

10 Most Commonly Asked Questions About Which Antiplatelet Agent to Prescribe
The Neurologist 9:318-322, Adams,H.P. Jr., 2003

Endovascuular Embolectomy of Acute Basilar Artery Occlusion
Neurol 61:1421-1423, Yu,W.,et al, 2003

Perioperative Management of Patients Receiving Oral Anticoagulants: A Systematic Review
Arch Int Med 163:901-908, Dunn,A.S. &Turpie,A.G.G., 2003

Risks and Benefits of Anticoagulant and Antiplatelet Medication Use Before Cataract Surgery
Ophthalmology 110:1784-1788, Katz,J.,et al, 2003

"Computed Tomography-Negative" Intracerebral Hemorrhage
Arch Neurol 60:1156-1159, Packard,A.S.,et al, 2003

A Risk Score for Predicting Stroke or Death in Individuals with New-Onset Atrial Fibrillation in the Community
JAMA 290:1049-1056,1093, Wang,T.J.,et al, 2003

Stroke Prevention in Atrial Fibrillation
JAMA 290:1093-1095, Waldo,A.L., 2003

Effect of Intensity of Oral Anticoagulation on Stroke Severity and Mortality in Atrial Fibrillation
NEJM 349:1019-1026, Hylek,E.M.,et al, 2003

Antiplatelet Therapy in Aneurysmal Subarachnoid Hemorrhage, A Systematic Review
Stroke 34:2285-2289, Mees,S.M.D.,et al, 2003

Surgical Decompression of Patients with Large Middle Cerebral Artery Infarcts is Effective
Stroke 34:2304-2305,2307, Schwab,S.&Hacke,W., 2003

Surgical Decopression of Patients With Large Middle Cerebral Artery Infarcts is Effective:Not Proven
Stroke 34:2305-2306,2307, Brown,M.M., 2003

Should I Start All My Ischaemic Stroke and TIA Patients on a Statin, an ACE Inhibitor, a Diuretic, and Aspirin Today?
JNNP 74:1461-1464, Sandercock,P.A.G., 2003

Continuation of Medically Necessary Aspirin and Warfarin During Cutaneous Surgery
Mayo Clin Proc 78:1392-1396, Otley,C.C., 2003

Detrminental Effect of Blood Pressure Reduction in the First 24 Hours of Acute Stroke Onset
Neurol 61:1047-1051,1030, Oliveira-Filho,J.,et al, 2003

Stroke
Lancet 362:1211-1224, Warlow,C.,et al, 2003

Stroke Risk in Anticoagulated Patients with Atrial Fibrillation Undergoing Endoscopy
Neurol 61:964-968, Blacker,D.J.,et al, 2003

The Medial Brachial Fascial Compartment Syndrome Following Axillary Arteriography
Neurol 61:1037-1041, Tsao,B.E. &Wilbourn,A.J., 2003

A 50-Year-Old Woman With Atrial Fibrillation
JAMA 290:2182-2189, Singer,D.E., 2003

Combined Stent Placement and Thrombolysis in Acute Vertebrobasilar Ischemic Stroke
AJNR 24:1827-1833, Lin,D.D.M.,et al, 2003

Surgical Decompression for Cerebral Edema in Acute Ischemic Stroke
Stroke 34:1337, Morley,N.C.D.,et al, 2003

Hemi-orolingual Angioedema and ACE Inhibition After Alteplase Treatment of Stroke
Neurol 60:1525-1527,1403, Hill,M.D.,et al, 2003

Immediate Reocclusion Following a Successful Thrombolysis in Acute Stroke: A Pilot Study
Neurol 60:1684-1687, Heo,J.H.,et al, 2003

Intra-arterial Thrombolysis in 24 Consecutive Patients with Internal Carotid Artery T Occlusions
JNNP 74:739-742, Arnold,M.,et al, 2003

Neuronal Regenration After Stroke
NEJM 348:2355-2356, Nadareishvili,Z. &Hallenbeck,J., 2003

Oral Anticoagulation in Patients After Cerebral Ischemia of Arterial Origin and Risk of Intracranial Hemorrhage
Stroke 34:e45, ESPRIT, 2003

Impact of Establishing a Primary Stroke Center at a Community Hospital on the Use of Thrombolytic Therapy
Stroke 34:e55, Lattimore,S.U.,et al, 2003

Perfusion-Weighted Magnetic Resonance Imaging Thresholds Identifying Core, Irreversibly Infarcted Tissue
Stroke 34:1425-1430, Shih,L.C.,et al, 2003

Cerebral Ischemic Events After Diagnosis of Mitral Valve Prolapse
Stroke 34:1339-1345, Avierinos,J.,et al, 2003

Anticoagulants Versus Antiplatelet Agents for Acute Ischemic Stroke
Stroke 34:1571-1572, Berge,E. &Sandercock,P., 2003

Arterial Thrombosis Induced by IVIg and Its Treatment with tPA
Neurol 60:1825-1826,1736, Okuda,D.,et al, 2003

Efficacy of IV Tisuse Plasminogen Activator in Acute Stroke
Neurol 61:71-75, Hsia,A.W.,et al, 2003

Can Patients be Anticoagulated After Intracerebral Hemorrhage?
Stroke 34:1710-1716, Eckman,M.H.,et al, 2003

Determination of Lipid Profiles and Use of Statins in Patients With Ischemic Stroke or Transient Ischemic Attack
Stroke 34:105-110, Lalouschek,W.,et al, 2003

Resolved: Heparin May Be Useful in Selected Patients with Brain Ischemia
Stroke 34:230-231, Caplan,L.R., 2003

In-Hospital Care Pathways for Stroke: A Cochrane Systematic Review
Stroke 34:587-588, Kwan,J. &Sandercock,P., 2003

Are Some Patients Likely to Benefit From Recombinant Tissue-Type Plasminogen Activator for Acute Ischemic Stroke Even Beyond 3 Hours From Symptom Onset?
Stroke 34:464-467, Kent,D.M.,et al, 2003

Hyperbaric Oxygen Therapy in Acute Ischemic Stroke
Stroke 34:571-574, Rusyniak,D.E.,et al, 2003

Imaging-Based Decision Making in Thrombolytic Therapy for Ischemic Stroke
Stroke 34:575-583, Schellinger,P.D.,et al, 2003

Asymptomatic Microbleeds as a Risk Factor for Aspirin-Associated Intracerebral Hemorrhages
Neurol 60:511-513, Wong,K.S.,et al, 2003

Use of a Field-to-Stroke Center Helicopter Transport Program to Extend Thrombolytic Therapy to Rural Residents
Stroke 34:729, Silliman,S.L.,et al, 2003

Telemedicine for Acute Stroke
Stroke 34:725, LaMonte,M.P.,et al, 2003

Early Major Ischemic Changes on Computed Tomography Should Preclude Use of Tissue Plaminogen Activator
Stroke 34:820-821,822, von Kummer,R., 2003

Early Major Ischemic Changes on Computed Tomography Should Not Preclude Use of Tissue Plasminogen Activator
Stroke 34:821-822,822, Lyden,P.,et al, 2003

Oral Anticoagulants Versus Antiplatelet Therapy for Preventing Further Vascular Events After Transient Ischemic Attack or Minor Stroke of Presumed Arterial Origin
Stroke 34:234-235, Algra,A.,et al, 2003

Bilateral Vertebral Artery Occlusion Resulting from Giant Cell Arteritis: Report of 3 Cases and Review of the Literature
Medicine 82:1-12, Ruegg,S.,et al, 2003



Showing articles 1150 to 1200 of 2192 << Previous Next >>